Advancing a food loss and waste bioproduct industry: A critical review of policy approaches for application in an Australian context

Food loss and waste (FLW) contains an abundance of nutrient components that can be extracted and converted into valuable bioproducts through biorefining (e.g., pharmaceuticals, cosmetics, nutrients). Australia has identified bioproducts from a FLW feedstock as one avenue through which it can meet its commitment to UN Sustainable Development Goal Target 12.3, aiming to halve food waste by 2030. An industry for bioproducts in Australia is, however, nascent and will require targeted and sustained policy intervention to advance in line with the production targets it has set to meet Target 12.3. The aim of this critical review is threefold. Firstly, it draws on the research literature to identify barriers to advancing a bioproduct industry from FLW. Secondly, it constructs a taxonomy of policies available to overcome these barriers and support industry development. Finally, it applies the taxonomy to established policy settings in Australia (examining both national settings and Queensland state settings) and the European Union (EU), where the industry and associated policy is more mature. Australia has few national policies directly targeting a bioproduct industry. A comparative assessment of policy settings allows this review to identify lessons Australia can draw from the EU experience as it advances its own industry. Findings demonstrate a complex and fragmented policy landscape. Key recommendations from the literature emphasise the need to establish coordinated strategic instruments; target research and development opportunities for optimised, sustainable processes; and implement appropriate incentives to establish a 'level playing field', as technology readiness increases. The critical requirement for policy stability and coherence, flags the need to lay groundwork policy in this area as a priority.

An Upper-Division, Remote Microbiology Laboratory That Blends Virtual and Hands-on Components to Promote Student Success during the COVID-19 Pandemic

The COVID-19 shutdown forced many institutions of higher education to shift in-person teaching to emergency remote teaching. This was particularly challenging for laboratory courses, where students are expected to learn hands-on skills needed for their career goals. Here, we describe the transformation of an upper-division microbiology laboratory to a course that seamlessly integrates online simulations with safe, hands-on experiences that can be done from home. This blended lab course helped students attain learning outcomes similar to those achieved in the in-person class. We illustrate the implementation of Unknown Portfolios to help students gain the data analysis and critical thinking skills needed to identify an unknown microorganism. Our data show that students who took these online courses mastered material as well as students who took the lab in person, demonstrating proficiency in laboratory safety skills, hands-on techniques, and theoretical class content. Last, we explore online adaptations to enhance in-person lab classes, aiming at reducing the accessibility and equity gaps inherited in many courses, as well as discussing challenges that instructors might experience in this process.

Build a Sustainable Vaccines Industry with Synthetic Biology

The vaccines industry has not changed appreciably in decades regarding technology, and has struggled to remain viable, with large companies withdrawing from production. Meanwhile, there has been no let-up in outbreaks of viral disease, at a time when the biopharmaceuticals industry is discussing downsizing. The distributed manufacturing model aligns well with this, and the advent of synthetic biology promises much in terms of vaccine design. Biofoundries separate design from manufacturing, a hallmark of modern engineering. Once designed in a biofoundry, digital code can be transferred to a small-scale manufacturing facility close to the point of care, rather than physically transferring cold-chain-dependent vaccine. Thus, biofoundries and distributed manufacturing have the potential to open up a new era of biomanufacturing, one based on digital biology and information systems. This seems a better model for tackling future outbreaks and pandemics.

Value Chains for Industrial Biotechnology in the Bioeconomy-Innovation System Analysis

Industrial Biotechnology (IB) is considered as a key technology with a strong potential to generate new growth, spur innovation, increase productivity, and tackle environmental and climate challenges. Industrial Biotechnology is applied in many segments of the bioeconomy ranging from chemicals, biofuels, bioenergy, bio-based plastics, and other biomaterials. However, the segments differ profoundly regarding volume, price, type, and amount of needed feedstock, market condition, societal contributions as well as maturity, etc. This article aims to analyse a set of five different value chains in the technological innovation system (TIS) framework in order to derive adequate policy conclusions. Hereby, we focus on quite distinctive value chains to take into account the high heterogeneity of biotechnological applications. The analysis points out that policy maker have to take into account the fundamental differences in the innovation systems and to implement differentiated innovation policy to address system weaknesses. In particular, market formation is often the key bottleneck innovation systems, but different policy instruments for various application segments needed.